Condition
Dermatitis clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Dermatitis clinical trials that are recruiting, at sites in 11 countries (most in United States (2), Czechia (2), Italy (1)). By phase: Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 11Countries
Newest Dermatitis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Camoteskimab in adults with moderate-to-severe atopic dermatitis | Phase 2 | Birmingham, Alabama and 84 other locations | Recruiting | May 20, 2026 |
| Single subcutaneous dose of SHR-1894 in healthy adults | Phase 1 | Chengdu, Sichuan | Recruiting | Feb 17, 2026 |
| Post-marketing follow-up of 047 TD Dermatitis Cream for adults and children with atopic or contact dermatitis | — | Milan and 2 other locations | Recruiting | Jul 9, 2025 |
| Post-market follow-up of ChitoCare® Medical for scars, post-dermatological care, dermatitis, and acne | — | Prague and 1 other locations | Recruiting | Feb 27, 2025 |
| Testing cosmetics for skin compatibility | — | Bern | Recruiting | Jan 19, 2017 |
| Investigating how eczema treatments affect skin bacteria | Phase 2 | Bethesda, Maryland | Recruiting | Jun 29, 2012 |
All recruiting trials (6)
-
Camoteskimab in adults with moderate-to-severe atopic dermatitis
This trial tests different doses of camoteskimab versus placebo to see if it helps adults with moderate-to-severe atopic dermatitis who have not fully responded to standard treatments.
-
Single subcutaneous dose of SHR-1894 in healthy adults
This trial will test a single under-the-skin (subcutaneous) dose of SHR-1894 in healthy adults to see if it is safe and how the body processes it.
-
Post-marketing follow-up of 047 TD Dermatitis Cream for adults and children with atopic or contact dermatitis
This will try 047 TD Dermatitis cream twice a day for 28 days to see if it reduces severity and symptoms in children and adults with atopic or contact dermatitis.
-
Post-market follow-up of ChitoCare® Medical for scars, post-dermatological care, dermatitis, and acne
This project will try ChitoCare® Medical gel and spray to see if they are safe and help heal scars, skin after dermatologic procedures, dermatitis, and acne in people who use them.
-
Testing cosmetics for skin compatibility
This study is testing new and reformulated cosmetics on people's skin to see if they cause any irritation or allergic reactions.
-
Investigating how eczema treatments affect skin bacteria
This study is testing how different eczema treatments affect the skin bacteria in people with moderate to severe eczema and healthy volunteers.
Related topics
Quick answers
How many Dermatitis clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (2 trials), Czechia (2 trials), Italy (1 trial), China (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.